Technology and New Treatments to Help Those with Heart and Lung Conditions

On April 11 and 12, 2025, in Naples, an important European cardiology congress will take place, dedicated especially to patients with congenital and complex heart diseases. This event represents a unique opportunity to explore the latest technological innovations and advanced treatments in cardiology, with a focus on minimally invasive techniques and personalized care.

Among the key speakers at the event will be Dr. Berardo Sarubbi, Director of the Adult Congenital Heart Disease and Arrhythmias Department at Monaldi Hospital in Naples, who will present some of the most significant developments in the treatment of heart conditions.

Minimally Invasive Technologies for the Treatment of Pulmonary Insufficiency

A central topic of the congress will be the use of next-generation heart valves, which can be implanted in a minimally invasive way, without the need to open the chest. This technology represents a significant advantage for patients who, due to previous surgeries, may face complications or risks associated with more invasive procedures. In particular, this innovation is especially relevant for those suffering from pulmonary insufficiency, a condition in which the heart can no longer pump blood effectively to the lungs.

Prevention of Malignant Arrhythmias

Another key topic will be the prevention of malignant arrhythmias, heart rhythm disorders that, although rare, can have serious consequences. In recent years, thanks to technological advancements, it has become possible to more accurately identify at-risk patients and intervene promptly with targeted treatments, thereby improving patient safety and quality of life.

Innovative Treatments for Heart Failure

During the congress, innovative treatments for heart failure will also be discussed, a condition in which the heart cannot pump blood effectively. At Monaldi Hospital, approaches have been developed that combine the use of effective medications with electrical heart therapies. Additionally, daily treatments in the Day Hospital have been introduced, allowing patients to improve the strength of their heartbeat without the need for long hospital stays.

Advanced Technology: 3D Reconstruction and Telemedicine

A major step forward has also been achieved thanks to the use of new technologies, such as 3D heart reconstruction through artificial intelligence. This technology allows doctors to personalize procedures by selecting the most suitable valve for each individual patient. Additionally, remote monitoring via telemedicine is revolutionizing the management of patients with heart failure. At Monaldi Hospital, a system is in place that allows monitoring of 25 patients per day, tracking crucial parameters such as blood pressure, heart rate, and body weight. Thanks to this innovation, the medical team can intervene promptly in case of abnormalities, reducing hospital stay days by 35%.

The Future of Cardiac Care: Accessibility and Innovation

These new technologies not only improve the quality of care but also make it more accessible to all patients, including those living far from hospitals. Thanks to telemedicine and personalized treatments, patients with complex congenital heart diseases can receive continuous care, enhancing their safety and quality of life.

The European Cardiology Congress represents a key opportunity to stay updated on medical innovations and the new frontiers in the treatment of congenital heart diseases, reaffirming the importance of an increasingly personalized and technologically advanced approach.